Role of Low Dose Aspirin for the Prevention of Recurrent Miscarriage

Ambreen Fida; Summaira Hamza; Bibi Ruqia; Mounazza Rehman; Maleeha Khan; Sana Mir

doi:10.70749/ijbr.v3i4.1894

Authors

Ambreen Fida Department of Obstetrics & Gynaecology, Bolan Medical College Hospital, Quetta, Pakistan
Summaira Hamza Department of Obstetrics & Gynaecology, Bolan Medical College Hospital, Quetta, Pakistan
Bibi Ruqia Department of Obstetrics & Gynaecology, Bolan Medical College Hospital, Quetta, Pakistan.
Mounazza Rehman Department of Obstetrics & Gynaecology, Combined Military Hospital (CMH), Lahore, Pakistan
Maleeha Khan Department of Obstetrics & Gynaecology, Bolan Medical College Hospital, Quetta, Pakistan.
Sana Mir Department of Obstetrics & Gynaecology, Bolan Medical College Hospital, Quetta, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i4.1894

Keywords:

Low-dose aspirin, Recurrent miscarriage, Pregnancy outcomes

Abstract

Background: A considerable percentage of women have recurrent pregnancy loss (RPL), which is defined as two or more consecutive losses. RPL frequently has multiple underlying reasons, such as immunological and thrombotic factors. Since low-dose aspirin (LDA) possesses anti-inflammatory and anti-thrombotic qualities, it has been suggested as a preventative strategy. Objective: The objective of this study is to assess how low-dose aspirin can improve pregnancy outcomes and prevent recurrent miscarriages. Methods: This qualitative study was carried out in a Quetta tertiary care hospital. Purposive sampling was used to choose 120 women who had a history of repeated miscarriages. Semi-structured interviews were used to gather data, which were then subjected to thematic analysis. Findings: 66.7% of the 120 women took low-dose aspirin. Of these, 70.8% went on to have healthy, continuing pregnancies. Better results were obtained with preconception initiation. While mild problems including nausea and stomach discomfort were observed in a small number of individuals, the majority had no side effects. Conclusion: Women who had experienced repeated miscarriages seemed to benefit from low-dose aspirin, particularly if taken before becoming pregnant. It had few adverse effects and was generally well accepted, indicating that it might be a safe prophylactic measure.

Downloads

Download data is not yet available.

References

1. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999; 340:1796–1799. [PubMed: 10362823]

https://doi.org/10.1056/nejm199906103402304

2. Risch HA, Weiss NS, Clarke EA, Miller AB. Risk factors for spontaneous abortion and its recurrence. Am J Epidemiol. 1988; 128:420–430. [PubMed: 3273482

https://doi.org/10.1093/oxfordjournals.aje.a114982

3. Silver, RM.; Branch, DW. Sporadic and recurrent pregnancy loss. In: Reece, EA.; Hobbins, JC., editors. Medicine of the fetus and mother. 2nd Edition ed. Philadelphia: J.B. Lippincott Company; 1999. p. 195-216. NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

https://doi.org/10.1002/9780470753293.ch11

4. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003; 110:255–258. [PubMed: 14592543]

https://doi.org/10.1016/s0049-3848(03)00379-7

5. Di NM, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev. 2005; (2):CD004734. [PubMed: 15846729]

https://doi.org/10.1002/14651858.cd004734

6. Rubinstein M, Marazzi A, Polak de FE. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing vitro fertilization: a prospective, randomized, double-blind placebocontrolled assay. FertilSteril. 1999; 71:825–829.

https://doi.org/10.1016/s0015-0282(99)00088-6

7. Rai R, Regan L. Recurrent miscarriage. The lancet. 2006 Aug 12;368(9535):601-11.

https://doi.org/10.1016/s0140-6736(06)69204-0

8. Sugiura-Ogasawara M, Ozaki Y, Katano K, Suzumori N, Kitaori T, Mizutani E. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Human reproduction. 2012 Aug 1;27(8):2297-303.

https://doi.org/10.1093/humrep/des179

9. Xu X, Wang J, Zhu D, Yin J, Liu J, Wu X, Yang W, Hu Q, Ren Y, Zhang Z, Zhou P. Low-dose aspirin protects unexplained recurrent spontaneous abortion via downregulation of HMGB1 inflammation activation. Frontiers in Endocrinology. 2022 Nov 17; 13:914030.

https://doi.org/10.3389/fendo.2022.914030

10. Kaandorp SP, Goddijn M, Van Der Post JA, Hutten BA, Verhoeve HR, Hamulyák K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Büller HR. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine. 2010 Apr 29;362(17):1586-96.

https://doi.org/10.1056/nejmoa1000641

11. Man R, Morton VH, Devani P, Morris RK. Aspirin for preventing adverse outcomes in low-risk nulliparous women with singleton pregnancies: A systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021 Jul 1; 262:105-12.

https://doi.org/10.1016/j.ejogrb.2021.05.017

12. Schisterman EF, Silver RM, Lesher LL, Faraggi D, Wactawski-Wende J, Townsend JM, Lynch AM, Perkins NJ, Mumford SL, Galai N. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial. The Lancet. 2014 Jul 5;384(9937):29-36.

https://doi.org/10.1016/s0140-6736(14)60157-4

13. Mansour MY, Gebriel MM, Abdelmoaty MA. Effect of Low Dose Aspirin on Luteal Phase Uterine Artery Doppler Indices in Women with Recurrent Pregnancy Loss. International Journal of Medical Arts. 2022 Sep 1;4(9):2657-63.

https://doi.org/10.21608/ijma.2022.165107.1519

14. Ye Y, Wen L, Liu X, Wang L, Liu Y, Saffery R, Kilby MD, Tong C, Qi H, Baker P. Low-dose aspirin for primary prevention of adverse pregnancy outcomes in twin pregnancies: an observational cohort study based on propensity score matching. BMC pregnancy and childbirth. 2021 Dec;21:1-8.

https://doi.org/10.1186/s12884-021-04217-2

15. Tanimura K, Saito S, Tsuda S, Ono Y, Deguchi M, Nagamatsu T, Fujii T, Nakatsuka M, Kobashi G, Arase H, Yamada H. Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-β2 glycoprotein I/HLA-DR autoantibodies: A prospective, multicenter, observational study. Frontiers in 26;15:1445852.

https://doi.org/10.3389/fimmu.2024.1445852

16. Mourisa C. Benefits of Low-Dose Aspirin During Pregnancy: A Systematic Review. Buletin Farmatera. 2023 Jun 30;8(2):13-25.

17. Swain, S., & Singh, S. (2017). The effect of low dose aspirin and low molecular weight heparin (enoxaparin) in recurrent pregnancy loss associated with antiphospholipid antibody syndrome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6(11), 4936-4940.

https://doi.org/10.18203/2320-1770.ijrcog20174652

18. Wang, T., et al. (2020). Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss. International Journal of Gynecology & Obstetrics, 150(1), 77-82.

https://doi.org/10.1002/ijgo.13160

19. Schisterman, E. F., et al. (2014). Preconception low-dose aspirin and pregnancy outcomes: findings from the EAGeR randomized trial. The Lancet, 384(9937), 29-36.

https://doi.org/10.1016/s0140-6736(14)60157-4

20. Carp, H. J., et al. (1997). Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Fertility and Sterility, 68(1), 35-40.

21. American College of Obstetricians and Gynecologists. (2018). Low-dose aspirin use during pregnancy. ACOG Committee Opinion No. 743. Obstetrics & Gynecology, 132(1), e44-e52.

https://doi.org/10.1097/aog.0000000000002708